Active Pharmaceutical Ingredient (API) Supply for Valsartan

The contract pertains to the supply of bulk Valsartan active pharmaceutical ingredient (API) with comprehensive documentation covering its origin, synthetic pathway, purity levels, and adherence to United States Pharmacopeia standards. All materials must meet stringent quality controls to ensure compliance with regulatory requirements applicable to pharmaceutical manufacturing. The subcontract is issued under the NAICS code 325411, indicating classification within pharmaceutical and medicine manufacturing, and is administered by the Department of Defense through DLA Troop Support. The solicitation was posted on June 23, 2026, with a response deadline of July 23, 2026, at 7:00 PM. While specific delivery locations or point of contact details are not provided, the obligation to deliver fully documented, USP-compliant Valsartan API remains central to the agreement. The nature of the contract implies that the supplier must demonstrate robust validation of manufacturing processes and provide traceability throughout the supply chain to meet defense pharmaceutical procurement standards.